SecBot SecBot

MRK

Merck & Co., Inc.
NYSE· Pharmaceutical Preparations· Inc. NJ· CIK 0000310158 Biotech & Drug Discovery
$145.90 −1.86 (−1.26%)
Nov 16 4:00 PM ET · prev $147.76
Market cap
$362.4B
Mega cap
Consensus
Buy
71% Buy or better · 35 analysts
Median target
$165.00
+13% · range $105.00–186.00
1 year
+57.1%
from $92.86 · Nov 17
30 days
−0.0%
from $145.95
52-week range
$92.86–156.45
−7% from high · low Nov 17
Avg volume 20D
9.34M
shares / day
Short interest
26.60M
≈1.1% of shares · −0.8%
Days to cover
2.4
at average volume
Insider net
−$30.0M
0 buyers · 5 sellers · since May 5
New fund stakes
3
Q2 2026 13F · 2 exits
Reddit crowd
57°
Neutral · 3 mentions this week
SecBot read MIXED 19 reports · 90 days
Balance 2 bearish · 2 bullish · 1 mixed · 14 neutral oldest → newest, height = score
Avg score ·High conf. 17/19 ·Next FDA decision date, Mar 22, 2027

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $30.0M.

  • InstitutionsMIXED

    Q2 2026: 47 added (3 new), 35 trimmed or exited. Largest new: Qube Research & Technologies $134.2M, Temasek Holdings (Private) $104.9M.

  • AnalystsBULLISH

    25 of 35 rate it Buy or better. Median target $165.00 (+13%).

  • Short sellersSTEADY

    Short interest −0.8% to 26.60M shares. 2.4 days to cover, ≈1.1% of shares.

  • TrendRANGE

    0% below its 50-day average.

  • SocialQUIET

    Crowd 57° (neutral) this week from 3 mentions: 1 bullish, 0 bearish. No setup is alerting. Excludes 1 subscriber-only day.

Who's buying

13F· Q2 2026
3
new positions
2
exits
$286.7M
in new stakes
FundMoveSharesValue
Fisher Asset Management, LLCADD38,516,263$4.9B
Capital International InvestorsDOUBLED15,386,689$2.0B
VOYA INVESTMENT MANAGEMENT LLCADD6,484,756$833.3M
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEMTRIM5,398,744$693.7M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD3,966,523$509.7M
CITIGROUP INCADD3,614,905$464.5M
NORDEA INVESTMENT MANAGEMENT ABTRIM3,503,750$445.1M
Ensign Peak Advisors, IncADD3,364,831$432.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

35 analysts
Buy 71% rate it Buy or better
Strong Buy8Buy17Hold10Sell0Strong Sell0
12-month targets · 26 analysts

Price is inside the target range. Median implies +13%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 2, 2026Freedom Broker
MAINTAIN
MAINTAINHold
Nov 2, 2026Cantor Fitzgerald
MAINTAIN
MAINTAINNeutral
Oct 30, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Oct 30, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Oct 30, 2026Guggenheim
MAINTAIN
MAINTAINBuy
Oct 26, 2026Barclays
MAINTAIN
MAINTAINOverweight
Congressional trades
MRK trades disclosed by members of Congress, with disclosure delay.
5 members · 7 buys / 6 sells
DateMemberType AmountDisclosed
Oct 7, 2026 Ro KhannaDHouse Spouse account · Merck & Co Inc BUY $15K–$50K Nov 5, 2026 +29d
Oct 2, 2026 Ro KhannaDHouse Child account · Merck & Co Inc BUY $1K–$15K Nov 5, 2026 +34d
Sep 24, 2026 Maria Elvira SalazarRHouse Merck & Co Inc SELL $1K–$15K Oct 7, 2026 +13d
Sep 4, 2026 Ro KhannaDHouse Spouse account · Merck & Co Inc SELL $1K–$15K Oct 7, 2026 +33d
Aug 28, 2026 Michael McCaulRHouse Spouse account · Merck & Co Inc SELL $50K–$100K Oct 14, 2026 +47d
Aug 19, 2026 Maria Elvira SalazarRHouse Merck & Co Inc BUY $15K–$50K Sep 9, 2026 +21d
Aug 19, 2026 Maria Elvira SalazarRHouse Merck & Co Inc BUY $15K–$50K Sep 9, 2026 +21d
Aug 7, 2026 Ro KhannaDHouse Child account · Merck & Co Inc BUY $15K–$50K Sep 4, 2026 +28d
Jul 8, 2026 Ro KhannaDHouse Spouse account · Merck & Co Inc BUY $1K–$15K Aug 7, 2026 +30d
May 15, 2026 Ro KhannaDHouse Spouse account · Merck & Co Inc SELL $15K–$50K Jun 9, 2026 +25d

Insider ledger

Form 4
$0
bought · 0 insiders
$30.0M
sold · 5 insiders
DateInsiderTypeValue
Nov 1, 2026
DIAZ PAUL J
Director
Nov 1, 2026
AWARD$91.7K
Sep 30, 2026
Coe Mary Ellen
Director
Sep 30, 2026
AWARD$30.0K
Sep 30, 2026
Karsanbhai Surendralal Lanca
Director
Sep 30, 2026
AWARD$16.3K
Sep 30, 2026
Seidman Christine E
Director
Sep 30, 2026
AWARD$8.1K
Aug 13, 2026
Guindo Chirfi
EVP, Access, Policy & Comms
Aug 13, 2026
SELL$1.4M
Aug 12, 2026
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Aug 12, 2026
SELL$79.2K
Aug 12, 2026
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Aug 12, 2026
SELL$1.5M
Aug 12, 2026
Zachary Jennifer
EVP, General Counsel
Aug 12, 2026
EXERCISE$1.1M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 15, 2026 Clinical trial readout
🔒 Fresh data, subscribers only
Nov 12, 2026 SEC
Richard R. DeLuca Jr., an officer of Merck, filed a Form 144 notice of intent to sell 58,185 shares of common stock…
144 · Impact 2/10
Nov 9, 2026 SEC
In a final written decision, the PTAB held all challenged claims (1, 2, 5, and 7–33) of Halozyme's PH20 hyaluronidase…
PTAB-TRIAL · Impact 2/10
Nov 6, 2026 Event
WELIREG
Supplemental Approval · Labeling · BELZUTIFAN · TABLET · ORAL
Nov 3, 2026 SEC
Paul J. Diaz filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 200 shares of Merck…
3 · Impact 2/10
Nov 1, 2026 Insider
DIAZ PAUL J was granted 613.073 shares
Director @ $149.52 ($91.7K)
Oct 7, 2026 Congress
Ro Khanna buy
$15,001 - $50,000 · House
Oct 2, 2026 Congress
Ro Khanna buy
$1,001 - $15,000 · House

Washington

Corporate Lobbying

78 lobbying filings and 12 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
26,604,245
shares short
-0.8%
vs prior settlement
2.4
days to cover
≈1.1%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
20 drugs tracked · Drug pipeline →
Upcoming
Recent
Reddit Mentions per day, 14 days
Crowd this week 57° Neutral 1 bullish · 0 bearish
Mentions, 7 days 3 0 in posts · 3 in comments
Recent posts
Recent comments
All social signals and their track records

SecBot reports

34 filings · 6 bullish · 2 bearish · 1 mixed · 25 neutral
All MRK filing & press-release reports (34)